| Dr George Chukwuemeka Obinero, DO, MD | |
|
3401 W Gore Blvd, Lawton, OK 73505-6332 | |
| (580) 510-7037 | |
| (580) 510-7038 |
| Full Name | Dr George Chukwuemeka Obinero |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 3401 W Gore Blvd, Lawton, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215169321 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 005918 (Arizona) | Secondary |
| 207R00000X | Internal Medicine | 5607 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Comanche County Memorial Hospital | Lawton, OK | Hospital |
| Grady Memorial Hospital | Chickasha, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grady Memorial Hospital | 0648175778 | 36 |
| Comanche County Healthcare Corporation | 0749192433 | 83 |
News Archive
454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.
Miami, Hartford and Indianapolis ranked at the top in Press Ganey's annual report on patient satisfaction in hospital emergency departments. A survey of more than 1.6 million patients treated at 1,908 hospitals nationwide between Jan. 1 and Dec. 31, 2010 gauged their experiences and how satisfied they were with the treatment they received in the emergency department.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
› Verified 8 days ago
| Entity Name | Comanche County Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352690 PECOS PAC ID: 0749192433 Enrollment ID: O20031106000742 |
News Archive
454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.
Miami, Hartford and Indianapolis ranked at the top in Press Ganey's annual report on patient satisfaction in hospital emergency departments. A survey of more than 1.6 million patients treated at 1,908 hospitals nationwide between Jan. 1 and Dec. 31, 2010 gauged their experiences and how satisfied they were with the treatment they received in the emergency department.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
› Verified 8 days ago
| Entity Name | Grady Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750370268 PECOS PAC ID: 0648175778 Enrollment ID: O20031203000193 |
News Archive
454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.
Miami, Hartford and Indianapolis ranked at the top in Press Ganey's annual report on patient satisfaction in hospital emergency departments. A survey of more than 1.6 million patients treated at 1,908 hospitals nationwide between Jan. 1 and Dec. 31, 2010 gauged their experiences and how satisfied they were with the treatment they received in the emergency department.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
› Verified 8 days ago
| Entity Name | Tulsa Hospital Medicine Physicians Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144982711 PECOS PAC ID: 7214327832 Enrollment ID: O20211214000389 |
News Archive
454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.
Miami, Hartford and Indianapolis ranked at the top in Press Ganey's annual report on patient satisfaction in hospital emergency departments. A survey of more than 1.6 million patients treated at 1,908 hospitals nationwide between Jan. 1 and Dec. 31, 2010 gauged their experiences and how satisfied they were with the treatment they received in the emergency department.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Chukwuemeka Obinero, DO, MD Po Box 785, Lawton, OK 73502-0785 Ph: (580) 357-9984 | Dr George Chukwuemeka Obinero, DO, MD 3401 W Gore Blvd, Lawton, OK 73505-6332 Ph: (580) 510-7037 |
News Archive
454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.
Miami, Hartford and Indianapolis ranked at the top in Press Ganey's annual report on patient satisfaction in hospital emergency departments. A survey of more than 1.6 million patients treated at 1,908 hospitals nationwide between Jan. 1 and Dec. 31, 2010 gauged their experiences and how satisfied they were with the treatment they received in the emergency department.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
› Verified 8 days ago
Dr. Brian Gillam Birdwell, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4202 Sw Lee Blvd, Lawton, OK 73505 Phone: 580-248-9966 Fax: 580-248-8313 | |
Steve Egwuonwu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5604 Sw Lee Blvd Ste 245, Lawton, OK 73505 Phone: 580-536-0071 | |
Dr. Pradeep Kumar Mada, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3201 W Gore Blvd Ste 103, Lawton, OK 73505 Phone: 580-250-6555 Fax: 580-354-5942 | |
Anmol Baranwal, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 104 Nw 31st St, Lawton, OK 73505 Phone: 580-536-2121 | |
Dr. Mahakit Inklab, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 104 Nw 31st, Lawton, OK 73505 Phone: 580-536-2121 Fax: 580-536-2150 | |
Dr. Bette J. Bischoff Glidewell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 580-510-7037 Fax: 580-510-7038 | |
Dr. Paul Anthony Nioce, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2716 W Gore Blvd Ste C, Lawton, OK 73505 Phone: 580-357-3280 Fax: 580-276-4358 |